Progress and Hurdles for Follow-on Biologics

被引：38

作者：

Sarpatwari, Ameet ^{[1
]}

Avorn, Jerry

Kesselheim, Aaron S.

机构：

[1] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 372卷 / 25期

关键词：

D O I：

10.1056/NEJMp1504672

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2380 / 2382

页数：3

共 50 条

[31] 'Generic' or 'follow-on" biologics: scientific considerations and safety issues
Green, JD
Tsang, L
Cavagnaro, JA
EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (07) : 1019 - 1022
[32] Nonparametric Tests for Evaluation of Biosimilarity in Variability of Follow-on Biologics
Zhang, Nan
Yang, Jun
Chow, Shein-Chung
Chi, Eric
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (06) : 1239 - 1253
[33] 'Follow-on biologics': Ensuring continued innovation in the biotechnology industry
Manheim, BS
Granahan, P
Dow, KJ
HEALTH AFFAIRS, 2006, 25 (02) : 394 - 404
[34] Follow-on biologics in oncology - the need for global and local regulations
Hus, Iwona
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (06): : 461 - 466
[35] Statistical Test for Evaluation of Biosimilarity in Variability of Follow-On Biologics
Hsieh, Tsung-Cheng
Chow, Shein-Chung
Liu, Jen-pei
Hsiao, Chin-Fu
Chi, Eric
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (01) : 75 - 89
[36] Follow-on biologics: data exclusivity and the balance between innovation and competition
Henry Grabowski
Nature Reviews Drug Discovery, 2008, 7 : 479 - 488
[37] Global follow-on biologics - IBC's fifth annual conference
Wheelwright, Scott M.
IDRUGS, 2008, 11 (02) : 94 - 96
[38] No Longer "If," But "When": The Coming Abbreviated Approval Pathway for Follow-on Biologics
Kelly, Jeremiah J.
David, Michael
FOOD AND DRUG LAW JOURNAL, 2009, 64 (01) : 115 - 148
[39] BIOT 174-Scientific developments in the follow-on biologics debate
Moreira, Antonio R.
Hanson, Michael A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[40] Emerging Experience with Follow-On Biologics: Active Surveillance and Risk Management
Morris, Jon
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S267 - S267

← 1 2 3 4 5 →